physcione has been researched along with 1-hydroxyanthraquinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CJ; Geahlen, RL | 1 |
Kobayashi, N; Koyama, J; Morita, I; Nisino, Y; Osakai, T; Tokuda, H | 1 |
1 review(s) available for physcione and 1-hydroxyanthraquinone
Article | Year |
---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
1 other study(ies) available for physcione and 1-hydroxyanthraquinone
Article | Year |
---|---|
Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
Topics: Anthraquinones; Antiviral Agents; Buffers; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Emodin; Herpesvirus 4, Human; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Methylation; Models, Chemical; Virus Activation | 2008 |